Table 2 Clinical chemistry of study subjects.
PhA | MetS | ||||
|---|---|---|---|---|---|
no ED | ED | no ED | ED | p | |
(n = 35) | (n = 13) | (n = 21) | (n = 36) | ||
Cholesterol, mmol/L | 5.27 ± 0.7 | 5.33 ± 0.8 | 5.26 ± 1.1 | 5.30 ± 1.6 | NS |
LDL-C, mmol/L | 3.47 ± 0.7 | 3.32 ± 0.9 | 3.24 ± 0.9 | 3.21 ± 1.0 | NS |
HDL-C3,a, mmol/L | 1.61 ± 0.3 | 1.81 ± 0.4 | 1.20 ± 0.2 | 1.16 ± 0.3 | < 0.001 |
Triglycerides3,a, mmol/L | 0.94 ± 0.5 | 0.86 ± 0.4 | 2.49 ± 1.4 | 3.19 ± 5.1 | < 0.001 |
OxLDL, U/L | 71.8 ± 21.4 | 75.5 ± 35.5 | 78.5 ± 40.1 | 80.8 ± 33.5 | NS |
Glucose2,a, mmol/L | 5.49 ± 0.4 | 5.59 ± 0.6 | 6.54 ± 1.0 | 6.99 ± 2.2 | < 0.001 |
HbA1C2,a,% | 5.61 ± 0.2 | 5.60 ± 0.2 | 6.03 ± 0.6 | 6.47 ± 1.2 | < 0.001 |